The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

Vonda Vaden Bates’ husband “might have survived if we had not confused kindness with skilled, quality care,” she writes.

Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...

A House committee on Wednesday passed a bill to renew a program aimed at aiding development of drugs for rare diseases in ...

Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a beautiful day as well, despite forecasts suggesting a cloud or two will later hover about. Right now, the ...

Listen: BioMarin’s executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion’s AI bona fides ...

A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a home hospital ...